Jane Street Group, LLC Immunovant, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$27.51 - $27.51 $1.88 Million - $1.88 Million
68,500 New
68,500 $1.88 Million
Q4 2021

Feb 15, 2022
SELL
$7.33 - $9.32 $3.37 Million - $4.29 Million
-460,400 Reduced 84.68%
83,300 $710,000
Q3 2021

Nov 16, 2021
SELL
$7.01 - $11.37 $967,380 - $1.57 Million
-138,000 Reduced 20.24%
543,700 $4.73 Million
Q2 2021

Aug 16, 2021
BUY
$9.4 - $16.85 $6.41 Million - $11.5 Million
681,700 New
681,700 $7.21 Million

Others Institutions Holding IMVT

# of Institutions
212
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email